- Home
- LVRO vs ARCT Comparison
LVRO vs ARCT Comparison
Compare LVRO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LVRO | ARCT |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.6M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LVRO | ARCT |
|---|---|---|
| Price | $0.73 | $7.52 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $1.88 | ★ $38.67 |
| AVG Volume (30 Days) | 13.3K | ★ 893.2K |
| Earning Date | 10-31-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,667,345,189.00 | $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.71 | $5.85 |
| 52 Week High | $5.60 | $24.17 |
Technical Indicators
Market Signals| Indicator | LVRO | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 26.88 | 43.53 |
| Support Level | $0.71 | $7.04 |
| Resistance Level | $0.96 | $7.76 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | -0.01 | 0.46 |
| Stochastic Oscillator | 0.00 | 87.05 |
Price Performance
Historical ComparisonAbout LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.